|
[1]LEE YJ,LEE JM,LEE JS,et al.Hepatocellular carcinoma:diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis[J].Radiology,2015,275(1):97-109.
|
|
[2]KIERANS AS,KANG SK,ROSENKRANTZ AB.The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm:a meta-analysis[J].Radiology,2016,278(1):82-94.
|
|
[3]ZENG MS,YE HY,GUO L,et al.Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients:a multicenter,open-label,phase III study[J].Hepatobiliary Pancreat Dis Int,2013,12(6):607-616.
|
|
[4]DING Y,RAO SY,CHEN CZ,et al.Gd+-EOB-DTPA-enhanced magnetic resonance imaging findings and diagnosis of small focal lesions in the liver[J].Radiol Pract,2013,28(9):934-938.(in Chinese)丁莺,饶圣祥,陈财忠,等.肝脏常见小局灶性病变的Gd+-EOB-DTPA磁共振增强表现与诊断[J].放射学实践,2013,28(9):934-938.
|
|
[5]DING Y,RAO SY,CHEN CZ,et al.Gd+-EOB-DTPA magnetic resonance imaging findings of multi-step cancer evolution of liver cirrhotic nodules[J].Radiol Pract,2013,28(5):514-517.(in Chinese)丁莺,饶圣祥,陈财忠,等.肝硬化结节多步癌演变的Gd+-EOB-DTPA的磁共振表现[J].放射学实践,2013,28(5):514-517.
|
|
[6]Ministry of Health of the People's Republic of China.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
|
|
[7] DING Y,CHEN CZ,RAO SX,et al.A compared study on Gd+-EOB-DTPA and Gd+-DTPA-enhanced MRI in detection of hepatocellular carcinoma[J].Chin J Gen Surg,2013,28(9):682-685.(in Chinese)丁莺,陈财忠,饶圣祥,等.Gd+-EOB-DTPA与Gd+-DT-PA增强磁共振检查肝细胞癌的对照研究[J].中华普通外科杂志,2013,28(9):682-685.
|
|
[8]KUDO M,MATSUI O,SAKAMOTO M,et al.Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma:consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan[J].Oncology,2013,84(Suppl 1):21-27.
|
|
[9]YOO SH,CHOI JY,JANG JW,et al.Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma[J].Ann Surg Oncol,2013,20(9):2893-2900.
|
|
[10]WANG JH,CHEN TY,OU HY,et al.Clinical impact of gadoxetic acid-enhanced magnetic resonance imaging on hepatoma management:a prospective study[J].Dig Dis Sci,2016,61(4):1197-1205.
|
|
[11]LEE DH,LEE JM,BAEK JH,et al.Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines:correlation with histopathologic findings[J].Radiology,2015,274(1):149-160.
|
|
[12]XIE S,LIU C,YU Z,et al.One-stop-shop preoperative evaluation for living liver donors with gadoxetic acid disodium-enhanced magnetic resonance imaging:efficiency and additional benefit[J].Clin Transplant,2015,29(12):1164-1172.
|
|
[13]MOTOSUGI U,ICHIKAWA T,SOU H,et al.Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging[J].Radiology,2010,256(1):151-158.
|
|
[14]SHINAGAWA Y,SAKAMOTO K,FUJIMITSU R,et al.Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma:clinicoradiologic correlation[J].AJR Am J Roentgenol,2012,199(5):1010-1017.
|
|
[15]MUHI A,ICHIKAWA T,MOTOSUGI U,et al.Diagnosis of colorectal hepatic metastases:comparison of contrast-enhanced CT,contrast-enhanced US,superparamagnetic iron oxide-enhanced MRI,and gadoxetic acid-enhanced MRI[J].J Magn Reson Imaging,2011,34(2):326-335.
|
|
[16]DING Y,ZENG MS,RAO SX,et al.Gd+-EOB-DTPA-enhanced MRI evaluation of colorectal liver metastases and chemotherapy-induced fatty liver[J].Diagn Imag Interv Radiol,2014,23(6):455-460.(in Chinese)丁莺,曾蒙苏,饶圣祥,等.肝细胞特异性对比剂普美显对结直肠癌肝转移的显示能力研究[J].影像诊断与介入放射学,2014,23(6):455-460.
|
|
[17]BERGER-KULEMANN V,SCHIMA W,BAROUD S,et al.Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetectorrow CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference[J].Eur J Surg Oncol,2012,38(8):670-676.
|
|
[18]DING Y,RAO SX,MENG T,et al.Preoperative evaluation of colorectal liver metastases:comparison of gadopentetate dimeglumine and gadoxetic-acid-enhanced 1.5-T MRI[J].Clin Imaging,2014,38(3):273-278.
|
|
[19]KIM HJ,LEE SS,BYUN JH,et al.Incremental value of liver MRimaging in patients with potentially curable colorectal hepatic metastasis detected at CT:a prospective comparison of diffusion-weighted imaging,gadoxetic acid-enhanced MR imaging,and a combination of both MR techniques[J].Radiology,2015,274(3):712-722.
|
|
[20]MCINNES MD,HIBBERT RM,INCIO JR,et al.Focal nodular hyperplasia and hepatocellular adenoma:accuracy of gadoxetic acid-enhanced MR imaging---a systematic review[J].Radiology,2015,277(2):413-423.
|
|
[21]WANG Y,XIAO XJ,LU BL,et al.Diagnostic value of Gd-EOB-DTPA in hepatic focal nodular hyperplasia[J].J Sun Yat-Sen Univ:Medical Sciences,2015,36(2):269-274.(in Chinese)王影,肖晓娟,卢宝兰,等.Gd-EOB-DTPA对肝局灶性结节增生的诊断价值探讨[J].中山大学学报:医学科学版,2015,36(2):269-274.
|
|
[22]TSE JR,NAINI BV,LU DS,et al.Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas[J].Radiology,2016,279(1):118-127.
|
|
[23]KANTARC-M,PIRIMOGLU B,KARABULUT N,et al.Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MRcholangiography:comparison with T2-weighted MR cholangiography[J].Eur Radiol,2013,23(10):2713-2722.
|
|
[24]PIETRYGA JA,BURKE LM,MARIN D,et al.Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium:examination recovery with a multiple arterial phase acquisition[J].Radiology,2014,271(2):426-434.
|
|
[25]van KESSEL CS,VELDHUIS WB,van den BOSCH MA,et al.MR liver imaging with Gd-EOB-DTPA:a delay time of 10-minutes is sufficient for lesion characterisation[J].Eur Radiol,2012,22(10):2153-2160.
|
|
[26]ESTERSON YB,FLUSBERG M,OH S,et al.Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease:associated clinical and imaging factors[J].Clin Radiol,2015,70(7):723-729.
|
|
[27]BASHIR MR,MERKLE EM.Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging[J].Eur Radiol,2011,21(2):291-294.
|
|
[28]LI RK,PALMER SL,ZENG MS,et al.Detection of endogenous iron reduction during hepatocarcinogenesis at susceptibility-weighted MR imaging:value for characterization of hepatocellular carcinoma and dysplastic nodule in cirrhotic liver[J].PLoS One,2015,10(11):e0142882.
|
|
[29]KITAO A,MATSUI O,YONEDA N,et al.Hypervascular hepatocellular carcinoma:correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images[J].Radiology,2012,265(3):780-789.
|
|
[30]CHEN CZ,RAO SX,DING Y,et al.Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients:early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine[J].Hepatol Int,2014,8(1):104-111.
|
|
[31]ZHANG SJ,RAO SX,CHEN J,et al.Comparative study of using Gd-EOB-DTPA and Gd-DTPA as MR contrast agent for hepatic parenchyma and vessles enhacement in the same patient with cirrhosis[J].Radiol Pract,2014,29(7):814-817.(in Chinese)张澍杰,饶圣祥,陈锦,等.Gd-EOB-DTPA与Gd-DTPA增强MR对肝硬化患者肝血管和肝实质增强效果的自身对照研究[J].放射学实践,2014,29(7):814-817.
|
|
[32]RINGE KI,HUSARIK DB,SIRLIN CB,et al.Gadoxetate disodium-enhanced MRI of the liver:part 1,protocol optimization and lesion appearance in the noncirrhotic liver[J].AJR Am J Roentgenol,2010,195(1):13-28.
|
|
[33]NASSIF A,JIA J,KEISER M,et al.Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging[J].Radiology,2012,264(3):741-750.
|
|
[34]DING Y,RAO SX,MENG T,et al.Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of nonalcoholic fatty liver disease[J].Eur Radiol,2014,24(4):959-966.
|
|
[35]DING Y,RAO SX,CHEN C,et al.Potential of Gd-EOB-DT-PA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits[J].Hepatol Int,2015,9(2):303-309.
|
|
[36]DING Y,RAO SX,ZHU T,et al.Liver fibrosis staging using T1mapping on gadoxetic acid-enhanced MRI compared with DW imaging[J].Clin Radiol,2015,70(10):1096-1103.
|
|
[37]DING Y,RAO SX,CHEN C,et al.Assessing liver function in patients with HBV-related HCC:a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI[J].Eur Radiol,2015,25(5):1392-1398.
|
|
[38]WU L,CAI HS,PENG XY,et al.Relationship between liver function and relative signal intensity of MR cholangiography using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid[J].Chin JRadiol,2013,47(8):726-730.(in Chinese)伍玲,蔡华崧,彭小英,等.钆塞酸二钠增强MR胆管成像与肝功能的相关性研究[J].中华放射学杂志,2013,47(8):726-730.
|
|
[39]XIE SS,JI Q,HOU JC,et al.Relationship between liver enhancement in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI and liver function[J].Chin J Radiol,2014,48(8):655-658.(in Chinese)谢双双,季倩,侯建存,等.肝功能对钆塞酸二钠增强MRI肝胆期肝脏强化程度的影响[J].中华放射学杂志,2014,48(8):655-658.
|
|
[40]DING Y,ZENG MS,RAO SX,et al.Assessment on T1 mapping values using gadoxetic acid-enhanced MRI examination in comparison with organic anion transporters and multi-drug resistance proteins values on the hepatocytes on colorectal liver metastases[J].Chin J Radiol,2015,49(3):195-198.(in Chinese)丁莺,曾蒙苏,饶圣祥,等.结直肠癌肝转移病灶钆塞酸二钠增强MRI纵向弛豫时间与肝细胞膜表面有机阴离子转运系统、多耐药蛋白载体含量的相关性[J].中华放射学杂志,2015,49(3):195-198.
|
|
[41]LIANG ML,ZHANG L,ZHANG JQ,et al.Evaluation of liver function reserve with gadoxetate disodium-enhanced MR[J].Chin J Radiol,2013,47(6):522-525.(in Chinese)梁明龙,张琳,张久权,等.利用钆塞酸二钠增强MR评估肝脏储备功能[J].中华放射学杂志,2013,47(6):522-525.
|
DownLoad: